Frederick Ferri, CEO of Natures Comfort Meds R&D (NCM), and John Diosa, CEO of the company Pharma Botanical Developers of Colombia, (PBD), announce their mutual collaboration and thus join other institutions that seek to achieve the following purpose; to develop a compound, derived from their research and development of cannabis, that can provide relief and save the lives of many people suffering from lung and bronchial inflammation caused by COVID-19, as well as other treatments or solutions to diseases. The intention is to raise the funds necessary with products derived from their mutual studies of cannabis.

Natures Comfort Meds Research and Development (established 2015) has developed a compound designed to treat the lung inflammation of COPD. Successful tests were completed at Beech Tree Labs (Providence, RI), and in conjunction with the University of Kentucky (Lexington, KY) and Primates Plus, during the past several years. Through their studies, they recently determined that this same compound developed to treat lung inflammation caused by COPD, would likely reduce the life-threatening bronchial and lung inflammation caused by SARS-CoV-2. This could be a significant development for the coronavirus responsible for the disease, COVID-19.

The R&D team of NCM includes doctoral-level researchers associated with Brown University and the University of Kentucky. They are also in the process of involving the University of Rhode Island College of Pharmacology. Their accelerated research work for a COVID-19 treatment is facing financial difficulties due to the disruption resulting from the global COVID-19 pandemic.

Fredd Ferri is aware that the Pope recently pledged substantial funding and has asked many around the world to support his efforts to provide funding to develop a treatment for COVID-19. Fredd met last week with Father Angelo Carusio from St.Rocco Parish (location?), who will support his request to the Bishop of RI and ultimately ask the Pope for financial support. The catholic church is being decimated by COVID-19 closures throughout the world, and this development by NCM could be a significant contribution to global healing given the funding the further the research/testing, etc.

PHARMA BOTANICAL DEVELOPERS SAS. Is a Colombian company in the agro-industrial sector, located near the city of Medellín, Colombia. As is well known, Colombia is poised to be the highest quality cannabis seed supplier in the world. PBD is dedicated to the research and development of products and services based on active principles of plant origin, mainly those of cannabis for medicinal purposes and recently, the Colombian government, through ICA, has certified its cultivars, which means that not only can it sell certified seed to the world, but it can also carry out genetic improvement, a fundamental process to favor the object of said collaboration. PBD has all the licenses, suitable personnel, and strategic alliances with universities such as the University of Antioquia, recognized worldwide for its

research and achievements, it also has a medical staff dedicated to the medicinal use of cannabis at a scientific level, which constitutes the favorable and friendly legal framework for the development of the investigation. It is a goal of this collaboration between NCM & PBD, and now it is expected to ally, Universidad de Antioquia Colombia, to reach the necessary agreements to obtain resources and thus achieve the integral development of said research of great humanitarian benefit.  Both companies believe that the newly developed, the patented compound could provide relief and save the lives of many people suffering from lung and bronchial i

inflammation caused by COVID-19.

The collaboration will continue with NCMBIOTECH scientific advisory board along with Prof. Raphael Mechoulam Ph.D.

And Prof. Hinanit Koltai of Israel.